Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Indication

stroke

283 clinical trials

281 products

8 drugs

Clinical trial
Placebo-Controlled, Double-Blind, Phase 2/3 Efficacy and Safety Trial of HLCM051 (MultiStem®) in Patients With Ischemic Stroke
Status: Completed, Estimated PCD: 2021-03-31
Product
Placebo
Product
HLCM051
Clinical trial
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Dose-range-finding Study to Evaluate the Efficacy and Safety of TF0023 Spray Versus Placebo in Functional Improvement of Patients With Ischemic Strokes
Status: , Estimated PCD: 2024-10-01
Product
TF0023
Clinical trial
STRATEGY FOR IMPROVING STROKE TREATMENT RESPONSE (SISTER) TRIAL
Status: Recruiting, Estimated PCD: 2027-07-01
Product
TS23
Product
tenecteplase
Product
alteplase
Clinical trial
A Phase III Multi-centre, Prospective, Randomised, Open Label, Blinded Endpoint (PROBE), Active-controlled Parallel Group Trial to Assess Efficacy and Safety of Tenecteplase Versus Alteplase in Chinese Patients With Acute Ischaemic Stroke Within 4.5 Hours After Stroke Onset
Status: Completed, Estimated PCD: 2023-10-08
Clinical trial
A Multicenter, Operationally Seamless, Double-Blind, Dose-Ranging, Placebo-Controlled, Randomized, Parallel-Group, Phase 2b Study to Evaluate the Efficacy and Safety of Intravenous BIIB131 for Participants With Ischemic Stroke Between 4.5 and 24 Hours After Last Known Well
Status: Withdrawn, Estimated PCD: 2025-07-07
Clinical trial
Long Term Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Central Neuropathy of Any Genesis
Status: Recruiting, Estimated PCD: 2024-09-30
Product
BIIB131
Product
Adezunap
Clinical trial
A Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety and Efficacy of Cerebrolysin in Patients With Acute Ischemic Stroke
Status: Completed, Estimated PCD: 2010-10-01
Product
Cerebrolysin
Product
0.9% Saline Solution
Clinical trial
A Multicenter, RandomiZed, Active-ControLled Study to Evaluate the Safety and Tolerability of Two Blinded Doses of Abelacimab (MAA868) Compared With Open-Label Rivaroxaban in Patients With Atrial Fibrillation (AZALEA)
Status: Active (not recruiting), Estimated PCD: 2023-12-14
Product
Rivaroxaban
Clinical trial
Prospective Randomized Study of the Modulating Effect of MEXIDOL® as an Adjuvant Stimulant of the Cognitive-emotional Component of the Rehabilitation Treatment of Patients With Acute Cerebral Failure
Status: Completed, Estimated PCD: 2023-09-12
Product
Mexidol
Product
Abelacimab
Clinical trial
A Multicenter, Double-blind, Placebo-controlled, Randomized Clinical Trial of Probucol in Reducing the Risk of Recurrent Stroke in Patients With Symptomatic Intracranial and Extracranial Large-artery Stenosis
Status: Not yet recruiting, Estimated PCD: 2026-04-30
Product
Probucol
Product
Placebo probucol
Clinical trial
A Phase 2, Double-Blind, Randomized, Placebo-Controlled, Hybrid Decentralized Study to Evaluate the Safety and Efficacy of Daily Subcutaneous (SC) Injection of TXA127 in Post-ischemic Stroke Patients
Status: Recruiting, Estimated PCD: 2024-12-01
Product
talfirastide
Clinical trial
A Randomized, Multi-Center, Prospective, Double Blind, Phase II Trial of RP- 1127 (Glyburide for Injection) in Patients With a Severe Anterior Circulation Ischemic Stroke Who Are Likely to Develop Malignant Edema
Status: Completed, Estimated PCD: 2016-04-04
Product
Glyburide
Product
Recombinant human tissue kallikrein
Clinical trial
Phase 2/3 Adaptive Design, Randomized Double-blind Placebo-controlled Study to Evaluate the Safety and Efficacy of DM199 for the Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)
Status: Recruiting, Estimated PCD: 2025-12-01
Clinical trial
RESCUE: A Randomized, Blinded, Placebo-controlled, Parallel Group Design to Determine the Safety of RNS60 in Large Vessel Occlusion Stroke Patients Undergoing Endovascular Thrombectomy
Status: Completed, Estimated PCD: 2023-11-08
Product
RNS60
Clinical trial
Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Central Neuropathy of Any Genesis
Status: Recruiting, Estimated PCD: 2024-09-30
Product
Non-Vitamin K Oral Antagonists
Clinical trial
Clinical Trial of Atrial Fibrillation Patients Comparing Left Atrial Appendage Occlusion Therapy to Non-vitamin K Antagonist Oral Anticoagulants
Status: Recruiting, Estimated PCD: 2027-08-01
Product
N,N-Dimethyltryptamine
Clinical trial
A Double-blind, Randomised, Placebo-controlled Study to Evaluate the Pharmacokinetics, Safety and Pharmacodynamics of Ascending Single and Fixed Repeat Intravenous Doses of DMT in Healthy Subjects
Status: Active (not recruiting), Estimated PCD: 2024-03-01
Product
Conditioned Medium
Clinical trial
Safety and Efficacy of Combined Conditioned Medium With Umbilical Cord Mesenchymal Stem Cells as A Novel Strategy for Acute Stroke Infarct
Status: Recruiting, Estimated PCD: 2023-12-01
Clinical trial
A Phase 1/2 Randomized Study to Evaluate the Safety and Tolerability of Intracarotid Artery Administration of NCS-01 in Patients With Acute Ischemic Stroke
Status: Recruiting, Estimated PCD: 2027-10-01
Product
MTR-601
Clinical trial
A Randomized, Double-Blind, Placebo-Controlled, First-in-Human, Single and Multiple Ascending Dose Study of MTR-601 in Healthy Volunteers.
Status: Recruiting, Estimated PCD: 2024-03-01
Product
NCS-01
Clinical trial
An Open-label, One-sequence, Three-period, Multiple-dose Study to Evaluate Drug-drug Interactions, Safety and Tolerability Between NDC-002A/NDC-002B and NDC-002C in Healthy Volunteers
Status: Completed, Estimated PCD: 2023-03-15
Product
NDC-002
Clinical trial
1-year Clinical Outcomes After Intravenous Rt-PA for Chinese AIS Patients
Status: Completed, Estimated PCD: 2022-11-30
Clinical trial
A Multicentre, Randomized, Double-blinded, Placebo-controlled, Parallel Group, Single-dose Design to Determine the Efficacy and Safety of Nerinetide in Participants With Acute Ischemic Stroke Undergoing Endovascular Thrombectomy Excluding Thrombolysis
Status: Completed, Estimated PCD: 2023-08-31
Product
Apixaban
Product
dabigatran
Product
rivaroxaban
Product
VKAs
Product
SP-8356
Clinical trial
A Phase I Single-Centre, Randomised, Double-Blind, Placebo-Controlled Study in Healthy Volunteers to Evaluate the Safety, Tolerability, and Pharmacokinetics of Escalating Single Doses and Multiple Doses of SP-8356
Status: Terminated, Estimated PCD: 2021-10-28
Clinical trial
A Multicentre, Randomized, Double-blinded, Placebo-controlled, Parallel Group, Single-dose Design to Determine the Efficacy and Safety of Intravenous NA-1 in Subjects With Acute Ischemic Stroke Undergoing Endovascular Thrombectomy
Status: Completed, Estimated PCD: 2019-11-20
Product
Nerinetide
Product
ApTOLL
Clinical trial
A Double-Blind, Placebo-Controlled, Randomized, Phase Ib/IIa Clinical Study of ApTOLL for the Treatment of Acute Ischemic Stroke
Status: Completed, Estimated PCD: 2022-07-25
Clinical trial
Stroke/Systemic Embolism and Major Bleeding in Patients Newly Treated With Oral Anticoagulants: a Real World Study From Portuguese Administrative Claims Data
Status: Withdrawn, Estimated PCD: 2020-12-01
Clinical trial
First in Human Clinical Trial to Compare Safety and Tolerability Between Intravenous Infusions and Bolus Intravenous Inhection of ApTOLL in Healthy Volunteers
Status: Completed, Estimated PCD: 2022-06-24
Product
Neu2000KWL
Clinical trial
A Phase III, Double-blind, Randomized, Placebo-controlled, Multi-center Study to Assess the Efficacy and Safety of Nelonemdaz in Patients With Acute Ischemic Stroke
Status: Recruiting, Estimated PCD: 2024-06-01
Product
rt-PA
Clinical trial
A Phase I Safety Trial of CTX0E03 Drug Product Delivered Intracranially in the Treatment of Patients With Stable Ischemic Stroke
Status: Completed, Estimated PCD: 2012-10-01
Product
Umbilical Cord Mesenchymal Stem Cells
Clinical trial
A Prospective, Multicentric, Randomized, Double-blind, Parallel, Phase III Clinical Study to Assess Efficacy of PMZ-1620 Along With Standard Treatment in Patients of Acute Ischemic Stroke
Status: Completed, Estimated PCD: 2022-02-10
Product
PMZ-1620
Product
Normal Saline
Clinical trial
Multi-center, Prospective, Cohort Study to Evaluate the Relationship of Stroke Recurrence and Anti-platelet Resistance in Ischemic Stroke Patients
Status: Completed, Estimated PCD: 2022-01-03
Product
MLC1501
Clinical trial
A Phase I, Open Label Study to Evaluate the Safety and to Explore the Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cells in Patients With Acute Ischemic Stroke
Status: Recruiting, Estimated PCD: 2024-12-31
Product
Aspirin
Clinical trial
A Multicenter, Double-blind, Placebo-controlled, Randomized Study of the Efficacy and Safety of Sequential Therapy With CYTOFLAVIN® (NTFF POLYSAN, Russia), Solution for Intravenous Infusion and Enteric-coated Tablets, in the Complex Rehabilitation of Patients With Acute Stroke
Status: Recruiting, Estimated PCD: 2024-09-01
Clinical trial
Effectiveness and Safety of IV Rt-PA Treatment in Chinese AIS Patients Aged Above 80 Years: a Real-world Study
Status: Completed, Estimated PCD: 2022-12-14
Product
Botulinum toxin type A
Clinical trial
Asian Multicentre, Double Blind, Randomised, Placebo Controlled Pilot Study, to Assess the Impact of Dysport® Intramuscular Injections When Administered Within the First 12 Weeks After Stroke on the Time to Spasticity Progression in Adult Subjects With Upper Limb (UL) Spasticity.
Status: Completed, Estimated PCD: 2016-03-01
Product
CTX0E03 neural stem cells
Clinical trial
A Randomized, Double-Blind, Placebo-Controlled, Dose-Response Efficacy and Safety Study of MLC1501 in Patients With Stroke
Status: Not yet recruiting, Estimated PCD: 2028-09-01
Product
Cytoflavin
Clinical trial
A Phase 3 Study to Evaluate the Efficacy and Safety of 3K3A-APC in Combination With Tissue Plasminogen Activator, Mechanical Thrombectomy, or Both in Subjects With Moderate to Severe Acute Ischemic Stroke
Status: Not yet recruiting, Estimated PCD: 2026-07-01
Product
UMSC01
Product
3K3A-APC
Clinical trial
Non-interventional Prospective Observational Study of Efficacy and Safety of Cytoflavin in Combination With Reperfusion Compared to Treatment With Other Neuroprotective Drugs Used in Routine Clinical Practice in Patients With Cerebral Infarction
Status: Completed, Estimated PCD: 2023-02-28
Product
Renexin CR
Product
Plavix
Product
Control
Clinical trial
A Prospective, Randomized, Active-controlled, Double-blind, Parallel, Multi-center, Phase IV, Exploratory Study to Evaluate the Efficacy and Safety of Renexin CR in Patients With Acute Non-cardioembolic Ischemic Stroke
Status: Recruiting, Estimated PCD: 2024-10-01
Clinical trial
A Prospective, Randomized, Double-blind Phase 2b Clinical Trial to Investigate the Efficacy and Safety of SP-8203 in Patients With Acute Ischemic Stroke Requiring Recombinant Tissue Plasminogen Activator (rtPA) Standard of Care
Status: Completed, Estimated PCD: 2020-10-19
Product
SP-8203
Clinical trial
A Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Efficacy and Safety of MLC1501 in Patients With Stroke
Status: Recruiting, Estimated PCD: 2024-05-30
Clinical trial
Characteristics and In-hospital Outcomes of Chinese Elderly (>80 Years) Patients With Acute Ischemic Stroke Receiving Intravenous Recombinant Tissue Plasminogen Activator Treatment Within 4.5 Hours of Symptom Onset
Status: Completed, Estimated PCD: 2023-03-28
Product
Naloxone hydrochloride
Product
Sodium Chloride
Clinical trial
A Placebo Controlled, Double-blind, Randomized, Multicenter Study to Evaluate the Efficacy and Safety of Naloxone HCl IV in Patients With Stroke
Status: Completed, Estimated PCD: 2022-10-25
Clinical trial
Comparative Study of the Mechanism of Action of Dry Needling and Botulinum Toxin Type A as a Treatment for Lower Limb Post-stroke Spasticity: a Proof of Concept Controlled Trial
Status: Not yet recruiting, Estimated PCD: 2026-03-31
Clinical trial
Complex Percutaneous Pulmonary Vein Isolation Combined With Left Atrial Appendage Occluder Implantation for Patients With Cardiogenic Ischemic Stroke in the Course of Atrial Fibrillation - PILOS-AF
Status: Not yet recruiting, Estimated PCD: 2025-06-30
Product
NOAC
Clinical trial
Drug Eluting Stenting and Aggressive Medical Treatment for Preventing Recurrent Stroke in Intracranial Atherosclerotic Disease Trial: a Prospective, Randomized, Open-labelled, Blinded End-point Trial (DREAM-PRIDE)
Status: Recruiting, Estimated PCD: 2025-07-01
Product
Aggressive medical treatment
Product
Standard medical treatment
Clinical trial
Stopping Cognitive Decline and Dementia by Fighting Covert Cerebral Small Vessel Disease
Status: Recruiting, Estimated PCD: 2027-11-01
Product
Blood sample
Clinical trial
Intensive Ambulance-delivered Blood Pressure Reduction in Hyper-Acute Stroke Trial
Status: Completed, Estimated PCD: 2023-11-23
Product
urapidil
Clinical trial
Randomization to EndoVascular Treatment Alone or Preceded by Systemic Thrombolysis With Tenecteplase in Acute Ischemic Stroke Due to Large Intracranial VEssel OcclusioN Trial - DIRECT Thrombectomy vs. Intravenous TNK Plus Thrombectomy
Status: Recruiting, Estimated PCD: 2026-07-01
Product
Tenecteplase
Clinical trial
The Efficacy and Safety of Low-dose Versus Standard-dose Rivaroxaban in Elderly Patients With Atrial Fibrillation
Status: Not yet recruiting, Estimated PCD: 2026-12-31
Clinical trial
General Anesthesia for Endovascular Thrombectomy; A Pilot Study.
Status: Completed, Estimated PCD: 2020-12-01
Product
Sevoflurane
Product
Lidocaine
Clinical trial
Rivaroxaban Versus Warfarin for Stroke Patients With Antiphospholipid Syndrome, With or Without SLE (RISAPS): a Randomised, Controlled, Open-label, Phase IIb, Non-inferiority Proof of Principle Trial.
Status: Active (not recruiting), Estimated PCD: 2025-02-01
Drug
Rivaroxaban
Clinical trial
Temporary Inactivation of Strong Muscle Sensation to Improve Rehabilitation Interventions in SCI
Status: Recruiting, Estimated PCD: 2024-06-04
Product
Lidocaine Cream
Clinical trial
Predictors of the Unfavourable Outcomes in Acute Ischemic Stroke Patients Treated With Alteplase, a Multi-centre Prospective Study
Status: Completed, Estimated PCD: 2023-06-03
Product
Alteplase
Clinical trial
Intra-Arterial Administration of Neuroprotective Agents and Cold Saline at Time of Recanalization for Acute Ischemic Stroke Due to Large Vessel Occlusion
Status: Recruiting, Estimated PCD: 2024-06-01
Product
Intra-arterial cold saline, minocycline, and magnesium
Clinical trial
Evaluation of Non-Vitamin K Antagonist Oral Anticoagulants Concentration Among Patients With Acute Stroke (The Direct Oral AntiCoagulant Registry in Taiwan-Emergent Department, DOACT-ED)
Status: Recruiting, Estimated PCD: 2025-12-01
Product
Dabigatran
Clinical trial
Aspirin Plus Rivaroxaban Efficacy and Safety in Embolic Stroke of Undetermined Source: A Randomized, Placebo Controlled, Outcome Assessor Blind, Feasibility Study
Status: Completed, Estimated PCD: 2023-04-10
Clinical trial
Escitalopram and Language Intervention for Subacute Aphasia (ELISA)
Status: Recruiting, Estimated PCD: 2025-09-18
Product
Escitalopram
Product
Warfarin
Clinical trial
OPtimal TIMing of Anticoagulation After Acute Ischaemic Stroke: a Randomised Controlled Trial
Status: Active (not recruiting), Estimated PCD: 2024-05-30
Product
Direct oral anticoagulant
Clinical trial
Lixiana Acute Stroke Evaluation Registry
Status: Completed, Estimated PCD: 2021-12-01
Product
Edoxaban
Clinical trial
Tirofiban for Patients With intraCranial Artery Stenosis and High-risk Acute Non-disabling Cerebrovascular Events(CHANCE-4）
Status: Not yet recruiting, Estimated PCD: 2025-06-01
Product
Tirofiban
Clinical trial
Blood Pressure Management in Stroke Following Endovascular Treatment
Status: Completed, Estimated PCD: 2023-02-04
Product
Labetalol
Product
Hydralazine
Clinical trial
Predictors of Post-alteplase Different Subtypes of Hemorrhagic Transformation of Brain Infarction in the Middle East
Status: Recruiting, Estimated PCD: 2023-10-30
Product
Enalapril
Clinical trial
A Phase III, Randomized, Multi-center Clinical Trial That Will Examine Whether Treatment With Intravenous TNK is Superior to Placebo in Patients Who Suffer a Non-large Vessel Occlusion Ischemic Stroke Within 4.5-12 Hours From Time Last Seen Well
Status: Recruiting, Estimated PCD: 2026-07-01
Clinical trial
European Society of Hypertension and Chinese Hypertension League Stroke in Hypertension Optimal Treatment Trial
Status: Completed, Estimated PCD: 2020-12-31
Clinical trial
Stroke Prophylaxis With Apixaban in Chronic Kidney Disease Stage 5 Patients With Atrial Fibrillation
Status: Recruiting, Estimated PCD: 2025-12-01
Clinical trial
Citicoline in Ischemic Stroke, a Randomized Placebo-controlled Trial
Status: Recruiting, Estimated PCD: 2024-06-29
Product
Citicoline
Clinical trial
Evaluation of the Efficacy and Safety of Mepivacaine on the Neurological Sequelae of Cerebral Infarction
Status: Recruiting, Estimated PCD: 2024-06-22
Product
Carbocaine
Clinical trial
Improving Cerebral Blood Flow and Cognition in Patients With Cerebral Small Vessel Disease. The ETLAS-2 Trial
Status: Recruiting, Estimated PCD: 2024-12-01
Product
Tadalafil
Clinical trial
The Role of Peripheral Afferents in Modulating Post-stroke Central Pain
Status: Recruiting, Estimated PCD: 2026-02-12
Product
Levobupivacaine
Product
Sodium Chloride 0.9%
Product
Antihypertensive drugs
Clinical trial
Ticagrelor Plus Aspirin vs Clopidogrel Plus Aspirin in Mild Non-cardioembolic Ischemic Stroke: A Randomized, Active Comparator Arm, Outcome Assessor Blind, Controlled, Feasibility Study
Status: Completed, Estimated PCD: 2023-10-10
Product
Ticagrelor
Product
Clopidogrel
Clinical trial
Comparison of the Efficacy of Ultrasound Guided vs Non-guided Suprascapular Nerve Block Treatment in Stroke Patients With Hemiplegic Shoulder Pain.
Status: Recruiting, Estimated PCD: 2024-03-30
Product
Ultrasound-guided Suprascapular Nerve Block
Product
Suprascapular Nerve Block
Clinical trial
What is the Optimal Antithrombotic Strategy in Patients With Atrial Fibrillation Having Acute Coronary Syndrome or Undergoing Percutaneous Coronary Intervention?
Status: Recruiting, Estimated PCD: 2027-10-01
Product
30-day DAPT
Clinical trial
Assessment Followed by Home-based Hybrid Robot + FES Rehabilitation Post-stroke
Status: Recruiting, Estimated PCD: 2026-10-01
Product
Ankle robot training
Product
Ankle robot training and functional electrical stimulation (FES)
Clinical trial
Tenecteplase Thrombolytic Therapy for Acute Ischemic Stroke in China a Real-world, Multicenter, Retrospective, Controlled Study
Status: Recruiting, Estimated PCD: 2023-12-01
Clinical trial
Anticoagulation Using Rivaroxaban on Top of Aspirin in Recent Stroke/Transient Ischemic Attack Patients With Intracranial Atherosclerotic Stenosis (AA-ICAS)
Status: Not yet recruiting, Estimated PCD: 2024-12-01
Drug
Aspirin
Product
Guideline-directed therapy
Clinical trial
Reduction of SystemiC Inflammation After Ischemic Stroke by Intravenous DNase Administration (ReSCInD)
Status: Not yet recruiting, Estimated PCD: 2025-12-01
Product
Dornase Alfa
Product
Isotonic Saline
Clinical trial
Effetti Della Nutrizione Sulla Fatica Post Stroke
Status: Completed, Estimated PCD: 2023-09-29
Product
SiderAl
Clinical trial
A Phase 1/Phase 2a Safety and Tolerability Study of Intracerebral Transplantation of Neural Stem Cells (NR1) in Subjects With Chronic Ischemic Subcortical Stroke (ISS) and Early Evaluation of Potentially Useful Efficacy Parameters
Status: Recruiting, Estimated PCD: 2024-12-31
Product
Neural Stem Cells
Clinical trial
Safety and Efficacy of Tirofiban in Acute Ischemic Stroke Patients Treated With Mechanical Thrombectomy-A Prospective, Randomized, Controlled, Open-Label, Assessor-Blind, Multicenter Clinical Study
Status: Completed, Estimated PCD: 2023-07-08
Clinical trial
Pilot Study of Memantine for Enhanced Stroke Recovery
Status: Active (not recruiting), Estimated PCD: 2025-05-01
Product
Memantine XR
Clinical trial
Effectiveness of Yangxue Qingnao Granules in Preventing Post Thrombolytic Hemorrhage Transformation in Patients With Acute Cerebral Infarction: a Randomized Controlled Study
Status: Active (not recruiting), Estimated PCD: 2025-01-01
Product
Yangxue Qingnao Granules
Clinical trial
The Efficacy and Safety of Y-3 Intracalvariosseous Injection Bypassing Blood-brain Barrier Versus Intravenous Injection in the Treatment of Acute Large Hemispheric Infarction（SOLUTION-2）
Status: Recruiting, Estimated PCD: 2025-09-15
Product
Y-3
Clinical trial
Enhancement of Stroke Rehabilitation With Levodopa (ESTREL): a Randomized Placebo-controlled Trial
Status: Recruiting, Estimated PCD: 2024-08-31
Product
IMP Levodopa/Carbidopa
Product
Matching placebo
Clinical trial
Expanded Access Multi-Patient Experimental Treatment Involving Allogeneic Human Mesenchymal Stem Cells (Allo-hMSCs) in Subjects With Acute Ischemic Stroke (EXPAND)
Status:
Product
Allogeneic human mesenchymal stem cells
Clinical trial
INSULIN
Status: Completed, Estimated PCD: 2016-12-31
Product
Insulin
Clinical trial
Effect of Interleukin-6 Receptor Inhibition for Avoiding Recurrence of Ischemic Stroke in Patients With Symptomatic Intracranial Atherosclerosis: a Double-blind, Randomized, Placebo-controlled Trial
Status: Not yet recruiting, Estimated PCD: 2025-12-31
Drug
Tocilizumab
Clinical trial
Evaluation of the Efficacy of Extracorporeal Shock Wave Therapy (ESWT) Following Botulinum Toxin Type A Injection on Post-Stroke Ankle Plantar Flexor Spasticity
Status: Completed, Estimated PCD: 2023-06-15
Product
BoNT A
Product
NaCl 0.9%
Clinical trial
Two-center, Prospective, Randomized, Open-label, Controlled Clinical Trial With Endpoint Evaluation
Status: Recruiting, Estimated PCD: 2025-01-01
Product
Colchicine
Clinical trial
A Randomised-controlled Trial of Donepezil for Motor Recovery in Acute Stroke
Status: Withdrawn, Estimated PCD: 2013-11-01
Product
Donepezil
Clinical trial
Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG
Status: Recruiting, Estimated PCD: 2025-06-30
Product
Antiplatelet-only strategy
Clinical trial
Intra-arterial Neuroprotective Strategy for Ischemic STroke Patients With No Reperfusion Therapy (INSIST-NRT): One Single Center, Safety and Feasibility Study
Status: Active (not recruiting), Estimated PCD: 2025-05-01
Product
Intra-arterial administration of neuroprotective agents
Clinical trial
Improving Stroke Prevention in Atrial Fibrillation Through Pharmacist Prescribing: Program for the Identification of 'Actionable' AF (PIAAF) Rx Study
Status: Completed, Estimated PCD: 2022-07-01
Drug
Anticoagulants
Clinical trial
Dual Thrombolytic Therapy With Mutant Pro-urokinase (M-pro-urokinase, HisproUK) and Low Dose Alteplase for Ischemic Stroke
Status: Completed, Estimated PCD: 2022-03-26
Product
Mutant Pro-urokinase
Product
Oral Anticoagulant
Clinical trial
Robot-Aided Assessment and Rehabilitation of Upper Extremity Function After Stroke
Status: Recruiting, Estimated PCD: 2024-05-30
Product
REACH robotic training and multi-muscle Functional Electrical Stimulation (FES) group
Product
Robot only group
Clinical trial
Left Atrial Appendage Occlusion Versus Novel Oral Anticoagulation for Stroke Prevention in Atrial Fibrillation. A Multicenter Randomized Clinical Trial. (Occlusion-AF)
Status: Recruiting, Estimated PCD: 2026-01-01
Clinical trial
Intravenous Tenecteplase for Acute Ischemic Stroke Within 4.5 to 6 Hours of Onset (EXIT-BT2): a Prospective, Randomized, Open Label, Blinded Endpoint, and Multi-center Study
Status: Recruiting, Estimated PCD: 2025-03-15
Clinical trial
Infliximab Therapy for Dolichoectactic Vertebrobasilar Aneurysms
Status: , Estimated PCD: 2025-06-01
Product
Infliximab
Clinical trial
Clinical and Biological Strokes Collection in Reunion Island
Status: Completed, Estimated PCD: 2023-06-21
Product
Biological Collection
Clinical trial
Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular Atherostenosis (CAPTIVA)
Status: Recruiting, Estimated PCD: 2027-05-31
Product
Ticagrelor + Aspirin
Clinical trial
Personalized Antiplatelet Secondary Stroke PRevenTion (PASSPoRT). A Randomized, Phase II, Open Label, Trial in High Risk Transient Ischemic Attack (TIA) and Ischemic Stroke Survivors Age 18 Years and Older
Status: Completed, Estimated PCD: 2023-05-09
Product
Tailored antiplatelet selection
Drug
standard of care
Clinical trial
Networked Drug REpurposing for Mechanism-based neuroPrOtection in Ischaemic STROKE (REPO-STROKE IIa)
Status: Recruiting, Estimated PCD: 2024-02-29
Product
Riociguat
Product
Propylthiouracil
Product
Perphenazine
Clinical trial
Upper Extremity Injection of Xeomin® and Changes in Gait Related Mobility in Adults After Stroke
Status: Recruiting, Estimated PCD: 2026-04-01
Product
Xeomin®
Clinical trial
Short-Term Anticoagulation Versus Antiplatelet Therapy for Preventing Device Thrombosis Following Left Atrial Appendage Closure. The ANDES Trial
Status: Recruiting, Estimated PCD: 2025-12-01
Product
Rivaroxaban + Aspirin
Product
Clopidogrel + Aspirin
Clinical trial
Intra-arterial Recombinant Human Tenecteplase Tissue-type Plasminogen Activator rhTNK-tPA) Thrombolysis for Acute Large Vessel Occlusion After Successful Mechanical Thrombectomy Recanalization -- A Multicenter, Prospective, Randomized, Open-label, Blinded End-point Trial (ANGEL-TNK)
Status: Recruiting, Estimated PCD: 2024-07-01
Product
Recombinant Human tenecteplase Tissue-type Plasminogen Activator
Clinical trial
The Effect of InTensive Statin in Ischemic Stroke With inTracranial Atherosclerotic Plaques: a Prospective, Random, Single-center Study Based on High Resolution Magnetic Resonance Imaging
Status: Recruiting, Estimated PCD: 2024-11-30
Product
Atorvastatin
Product
PCSK9 inhibitor
Clinical trial
Statins in Acute Ischemic Stroke(Role of Statins in Reperfusion in Acute Stroke )
Status: Not yet recruiting, Estimated PCD: 2025-02-28
Product
rosuvastatin
Clinical trial
Combination Anti-thrombotic Treatment for Prevention of Recurrent Ischemic Stroke in Intracranial Atherosclerotic Disease: Protocol for a Pilot Randomized Trial
Status: Completed, Estimated PCD: 2023-09-18
Product
Acetylsalicylic acid
Clinical trial
Periprocedural Continuation Versus Interruption of Oral Anticoagulant Drugs During Transcatheter Aortic Valve Implantation (POPular PAUSE TAVI)
Status: Completed, Estimated PCD: 2024-03-21
Product
Continuation of oral anticoagulants
Product
Interruption of oral anticoagulants
Clinical trial
Colchicine in Circulating Inflammatory Markers After Stroke
Status: Not yet recruiting, Estimated PCD: 2024-10-01
Clinical trial
Apixaban for the Reduction of Thrombo-Embolism in Patients With Device-Detected Sub-Clinical Atrial Fibrillation
Status: Completed, Estimated PCD: 2023-10-27
Clinical trial
The Role of Circadian Factors in Regulation of Neuroplasticity in Ischemic Stroke (Interventional)
Status: Recruiting, Estimated PCD: 2024-05-30
Product
Blue Light + Melatonin
Product
Melatonin
Clinical trial
Cyclopofol Versus Propofol for Postoperative Delirium in Elderly Patients Having Orthopedic Surgery: A Single-center Randomised Exploratory Trial
Status: Not yet recruiting, Estimated PCD: 2024-12-31
Product
Cyclopofol
Product
Propofol
Clinical trial
Trial of New Oral Anticoagulants vs. Warfarin for Post Cardiac Surgery Atrial Fibrillation
Status: Completed, Estimated PCD: 2023-10-01
Clinical trial
Ticagrelor Versus Cilostazol in Ischemic Stroke
Status: Recruiting, Estimated PCD: 2024-06-12
Clinical trial
Efficacy of a Glucagon-like-peptide-1 Agonist and Restrictive vs. Liberal Oxygen Supply in Patients Undergoing Coronary Artery Bypass Grafting or Aortic Valve Replacement - a 2-by-2 Factorial Designed, Randomized Clinical Study
Status: Active (not recruiting), Estimated PCD: 2024-01-01
Product
Byetta
Product
Conoxia
Product
Human Albumin
Clinical trial
Combining Use of Clopidogrel With Atorvastatin or Rosuvastatin in Patients With Large-vessel Ischemic Stroke, a Randomized Controlled Single-blinded Trial
Status: Recruiting, Estimated PCD: 2025-04-10
Product
Rosuvastatin
Clinical trial
Study on the Efficacy of Alprostadil Injection in Patients With Acute Ischemic Stroke
Status: Not yet recruiting, Estimated PCD: 2024-12-31
Product
Alprostadil
Product
Normal saline
Clinical trial
Efficacy and Safety of Mongolian Medicine ZhenBao Pills on Limb Function Recovery After Acute Ischemic Stroke: a Randomized Double-blinded Placebo-controlled Trial.
Status: Not yet recruiting, Estimated PCD: 2025-10-31
Product
ZhenBao Pills
Product
Mongolian Medicine ZhenBao Pills
Clinical trial
WATCHMAN FLX Versus NOAC for Embolic ProtectION in in the Management of Patients With Non-Valvular Atrial Fibrillation
Status: Active (not recruiting), Estimated PCD: 2027-12-01
Product
Non-Vitamin K Oral Anticoagulant
Product
Cilostazol
Clinical trial
A Multicentre, Prospective, Randomized, Open Label, Blinded-endpoint Trial to Optimize the Use of Intravenous Tenecteplase in Participants With Acute Ischemic Stroke (ACT-GLOBAL THROMBOLYSIS (ACT WHEN-001) Within A Multi-faCtorial, mulTi-arm, Multi-staGe, Randomised, gLOBal Adaptive pLatform Trial for Stroke (ACT-GLOBAL) NCT06352632
Status: Not yet recruiting, Estimated PCD: 2030-09-30
Clinical trial
Prospective International Multicenter Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety Evaluation of the Mexidol® Sequential Therapy of Patients in the Acute and Early Recovery Periods of Ischemic Stroke
Status: Completed, Estimated PCD: 2023-08-18
Clinical trial
A Randomized Controlled Trial to Assess the Effect of Intensive Blood Pressure Control on Major Cardiovascular Events in Stroke Patients
Status: Active (not recruiting), Estimated PCD: 2025-12-01
Product
Intensive Control of Systolic Blood Pressure
Product
Standard control of Systolic Blood Pressure
Clinical trial
Efficacy and Safety of Shuxuening Injection in the Treatment With Intravenous Thrombolysis in Patients With Ischemic Stroke: A Multicenter, Randomized, Double-blind, Placebo-parallel Controlled Trial
Status: Recruiting, Estimated PCD: 2025-06-01
Product
Shuxuening
Clinical trial
A Randomised Trial of Tenecteplase vs. Alteplase in Acute Ischemic Stroke
Status: Terminated, Estimated PCD: 2021-09-30
Clinical trial
Phase III Clinical Trial of Y-2 Sublingual Tablet in the Treatment of Acute Ischemic Stroke - a Multicenter, Randomized, Double-blind, Parallel, Placebo-controlled Phase III Clinical Trial
Status: Completed, Estimated PCD: 2022-08-10
Product
Y-2
Product
d-borneol
Clinical trial
Ticagrelor Versus Cilostazol in Ischemic Stroke
Status: Recruiting, Estimated PCD: 2024-01-20
Clinical trial
Real World Evidence Study for Assessing Statin Use for Primary and Secondary Prevention of Cardiovascular Disease in Primary Care in Brazil
Status: Completed, Estimated PCD: 2021-12-15
Product
Statin
Clinical trial
Stroke Minimization Through Additive Anti-atherosclerotic Agents in Routine Treatment II Study (SMAART II)
Status: Not yet recruiting, Estimated PCD: 2026-01-01
Product
Polycap
Clinical trial
MidregiOnal Proatrial Natriuretic Peptide to Guide SEcondary Stroke Prevention: The MOSES-study. An International, Multicentre, Randomised-controlled, Two-arm, Assessor-blinded Trial
Status: Recruiting, Estimated PCD: 2025-01-31
Clinical trial
Effect of Interleukin-6 Receptor Inhibition in Patients With Ischemic Stroke Undergoing Endovascular Treatment: a Double-blind, Randomized, Placebo-controlled Trial
Status: Recruiting, Estimated PCD: 2025-06-30
Clinical trial
Cerebroprotective Effect of Melatonin in Acute Ischemic Stroke
Status: Recruiting, Estimated PCD: 2025-03-15
Clinical trial
Transmission Electron Microscopy Images for Platelet Ultrastructural Criteria Before and After the Onset of an Antiplatelet Agent
Status: Not yet recruiting, Estimated PCD: 2025-06-01
Clinical trial
Precise Antiplatelet THerapy Guided by Platelet Aggregation Function in Acute Ischemic STROKE
Status: Recruiting, Estimated PCD: 2025-12-31
Product
Blood collection before antiplatelet treatment
Product
Precision Antiplatelet Therapy Trial Group
Product
Blood collection after antiplatelet treatment
Clinical trial
The Danish Warfarin-Dialysis Study: Safety and Efficacy of Warfarin in Patients With Atrial Fibrillation on Dialysis - A Nationwide Parallel-group Open Randomized Clinical Trial
Status: Recruiting, Estimated PCD: 2027-01-01
Product
Traditional Antiplatelet Therapy
Clinical trial
Efficacy and Safety of Propranolol for the Post-Stroke Pneumonia
Status: Recruiting, Estimated PCD: 2024-07-03
Product
Propranolol
Clinical trial
Effect of Butyphthalide on Cognitive Level Change After Cerebral Vascular Event-a Randomized Control Trial (Be-CLEVER)
Status: Recruiting, Estimated PCD: 2026-12-01
Product
dl-3-butylphthalide
Clinical trial
Comparison of Clopidogrel-based Antiplatelet Therapy Versus Warfarin as Secondary Prevention Strategy for AntiPhospholipid Syndrome-related STROKE (APS-STROKE)
Status: Recruiting, Estimated PCD: 2027-07-01
Product
Antiplatelet
Clinical trial
Multicentre, Prospective Randomized Open Label, Blinded-endpoint (PROBE) Controlled Trial of Thrombolysis With Low Dose Tenecteplase (TNK-tPA) Versus Standard of Care in Minor Ischemic Stroke With Proven Acute Symptomatic Occlusion
Status: Active (not recruiting), Estimated PCD: 2024-01-19
Clinical trial
Efficacy and Safety of Endovascular Thrombectomy Plus Medical Management Versus Medical Management Alone in Acute Ischemic Stroke Patients With Large Vessel Occlusion and Extra-Large Infarct Core: A Multicenter, Randomized Controlled Trial
Status: Not yet recruiting, Estimated PCD: 2026-10-31
Product
Medical Management
Clinical trial
Effects of Medical Treatment of Intracranial Atherosclerotic Diseases Based on Magnetic Resonance Fractional Flow Reserve
Status: Recruiting, Estimated PCD: 2024-06-01
Product
Anti-platelet therapy
Clinical trial
A Trial of Pharmacist Management of Oral Anticoagulation THerapy Versus Enhanced Usual CARe in the communitY for AF (APOTHECARY AF Study)
Status: Recruiting, Estimated PCD: 2024-08-31
Product
Oral anticoagulant
Product
Antiplatelet treatment
Product
DL-3-Butylphthalide
Clinical trial
Multicentre Randomized Trial of Ghrelin in Anterior Circulation Ischemic Stroke Treated With Endovascular Thrombectomy. A Randomized Phase 2 Trial
Status: Not yet recruiting, Estimated PCD: 2024-12-31
Product
Ghrelin
Clinical trial
CUHK Stroke Biobank
Status: Recruiting, Estimated PCD: 2025-12-31
Product
Gene expression or biomarkers exploration
Clinical trial
Treatment Targets for Inflamed Intracranial Atherosclerosis on Vessel Wall MRI
Status: Recruiting, Estimated PCD: 2024-11-27
Product
Ferumoxytol
Clinical trial
Clopidogrel Versus Cilostazol in Large-vessel Ischemic Stroke, a Randomized Controlled Trial
Status: Recruiting, Estimated PCD: 2025-01-01
Clinical trial
Resting State MRI Connectivity in Acute Ischemic Stroke: Serotonin Selective Reuptake Inhibitor (SSRI) in Enhancing Motor Recovery: a Placebo Controlled Study
Status: Completed, Estimated PCD: 2022-01-31
Product
Fluoxetine
Drug
Varlilumab
Clinical trial
The Neurotrophic Effects of Lithium Carbonate Following Stroke: A Feasibility Study
Status: Completed, Estimated PCD: 2017-07-25
Product
Lithium Carbonate
Clinical trial
Efficacy and Safety of Ticagrelor With Aspirin Dual Antiplatelet Therapy Combined With Intravenous Thrombolysis in Patients With Ischemic Stroke (TAPIS): a Multicenter, Randomized, Double-blind, Placebo-parallel Controlled Trial
Status: Not yet recruiting, Estimated PCD: 2025-12-01
Product
Early Dual Antiplatelet Therapy
Clinical trial
Regulating Blood Pressure During Recovery From Intracerebral Hemorrhage and Ischemic Stroke
Status: Recruiting, Estimated PCD: 2025-03-01
Product
Spironolactone
Clinical trial
Evaluation of the Efficacy of Dornase Alfa (Pulmozyme®) on Arterial Recanalization in Post-thrombectomy Angiography in Patients With Ischemic Stroke by Thrombolysis and Eligible for Thrombectomy (NETs-target)
Status: Recruiting, Estimated PCD: 2025-08-18
Product
Dornase alfa
Clinical trial
Genotype Guided Antiplatelet Therapy In Ischemic Stroke
Status: Recruiting, Estimated PCD: 2024-12-01
Product
Genetic testing
Clinical trial
Induced Hypertension in Acute PRogrESsive Perforating Artery Stroke Using Peripheral Dilute noREpinephrine
Status: Not yet recruiting, Estimated PCD: 2025-10-01
Product
Norepinephrine
Clinical trial
Intracranial Thrombectomy and Extracranial Carotid Stenting Versus Intracranial Thrombectomy Alone In Acute Anterior Circulation Strokes With TANdem Occlusion : the Randomized Controlled TITAN Trial
Status: Recruiting, Estimated PCD: 2025-10-30
Product
Dual dual antiplatelet therapy after 24-hours imaging follow-up
Clinical trial
Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors and the Risk of Cardiovascular Events Among Patients With Type 2 Diabetes: a Multicenter Cohort Study
Status: Completed, Estimated PCD: 2019-10-01
Product
Sodium-glucose cotransporter 2 inhibitors
Product
Dipeptidyl peptidase-4 (DPP-4) inhibitors
Clinical trial
Efficacy and Safety of Minocycline in Patients With Moderate to Severe Acute Ischemic Stroke: A Prospective, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Phase III Trial
Status: Recruiting, Estimated PCD: 2024-03-01
Product
Minocycline
Product
Minocycline hydrochloride
Clinical trial
Outcomes After Intravenous Alteplase / Tenecteplase With or Without Shuxuetong Injection in Routine Clinical Practice: A Patient Registry
Status: Not yet recruiting, Estimated PCD: 2025-04-30
Product
Shuxuetong
Clinical trial
Intra-arterial Thrombectomy as an Acute Treatment Intervention for Stoke: the Endovascular Acute Stoke Intervention (EASI) Trial
Status: , Estimated PCD: 2025-01-01
Product
Best standard treatment
Clinical trial
Évaluation de l'Effet d'Injections répétées de Hautes Doses de Toxine Botulique Dans le Membre inférieur de Sujets cérébrolésés Spastiques Sur Les paramètres Fonctionnels et biomécaniques de Marche
Status: Completed, Estimated PCD: 2021-12-31
Product
Xeomin
Clinical trial
Improving Neuroprotective Strategy for Ischemic Stroke With Sufficient Recanalization After Thrombectomy by Intra-arterial Cocktail Therapy (INSIST-CT): a Prospective, Single Arm, Pilot Study
Status: Completed, Estimated PCD: 2022-09-20
Product
Intra-arterial cocktail therapy
Clinical trial
A Randomized Placebo-controlled Trial of Methylphenidate in Veterans With a Diagnosis of Post Traumatic Stress Disorder and Recent Cerebral Stroke.
Status: Recruiting, Estimated PCD: 2026-09-30
Product
Methylphenidate
Clinical trial
The Effect of Early Administration of PCSK9 Inhibitor, Alirocumab to Acute Ischemic Stroke Patients Associated With Atherosclerosis on the Stroke Prognosis and Lipid Profile, a Single Center Study, Registry Based, Pragmatic, Prospective Trial
Status: Not yet recruiting, Estimated PCD: 2026-10-15
Product
Alirocumab
Clinical trial
Clopidogrel Versus Cilostazol in Ischemic Stroke, a Randomized Controlled Trial
Status: Recruiting, Estimated PCD: 2025-01-01
Clinical trial
Effect of Oral Minocycline on Acute Stroke Outcome: A Randomized Open Label Prospective Study
Status: Recruiting, Estimated PCD: 2025-11-01
Clinical trial
Upregulating Corticospinal Function After Stroke Using Brain State-dependent Paired Corticomotoneuronal Stimulation
Status: Recruiting, Estimated PCD: 2024-07-01
Product
Brain state-dependent paired corticomotoneuronal stimulation (PCMS)
Clinical trial
Extra Alirocumab in Addition to Statin Therapy in Symptomatic IntraCranial Atherosclerotic Stenosis ----a Pilot Study
Status: Recruiting, Estimated PCD: 2024-09-15
Drug
Atorvastatin
Clinical trial
Assessment of the WATCHMAN™ Device in Patients Unsuitable for Oral Anticoagulation (ASAP-TOO)
Status: Active (not recruiting), Estimated PCD: 2025-12-01
Product
Single Antiplatelet Therapy
Clinical trial
Endovascular Stroke Treatment And Reteplase Protocol
Status: Withdrawn, Estimated PCD: 2024-07-01
Product
Reteplase
Clinical trial
Stroke-induced Myocardial Dysfunction: Role of GDF-15 (SMOG-15) Clinical Work Package
Status: Recruiting, Estimated PCD: 2025-08-01
Product
Standard Biology
Product
Serum GDF-15
Product
Ultrasensitive Troponin-Ic
Clinical trial
Altering Activation Patterns in the Distal Upper Extremity After Stroke
Status: Active (not recruiting), Estimated PCD: 2019-08-01
Product
Cyproheptadine
Clinical trial
Pair Antiplatelet THerapy in Ischemic Stroke With Intracranial Artery Stenosis
Status: Recruiting, Estimated PCD: 2026-03-31
Clinical trial
An Observational Trial of Edaravone Dexborneol Combining With Mechanical Thrombectomy in the Treatment of Acute Ischemic Stroke
Status: Recruiting, Estimated PCD: 2023-10-31
Product
Edaravone
Clinical trial
Glucagon-like Peptide 1 Receptor Agonist in Acute Large Vessel Occlusion Stroke Treated by Reperfusion Therapies - a Pilot Study
Status: Recruiting, Estimated PCD: 2026-03-31
Product
Semaglutide
Clinical trial
Association of Osmotic Drugs With Clinical Outcomes in Acute Large Hemispheric Infarction: a Prospective, Multicenter, Observational Cohort Study
Status: Not yet recruiting, Estimated PCD: 2027-01-01
Product
Osmotic drugs
Clinical trial
Post-thrombectomy Intra-arterial Tenecteplase for Acute manaGement of Non-retrievable Thrombus and No-reflow in Emergent Stroke (EXTEND-AGNES TNK)
Status: Not yet recruiting, Estimated PCD: 2027-08-30
Clinical trial
SURGERY VS BOTULINUM TOXIN ON QUALITY OF LIFE IN STROKE PATIENTS
Status: Recruiting, Estimated PCD: 2024-06-01
Product
Botulinum Toxin A
Clinical trial
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous BIIB093 (Glibenclamide) for Severe Cerebral Edema Following Large Hemispheric Infarction
Status: Terminated, Estimated PCD: 2023-08-18
Product
BIIB093
Clinical trial
Early Closure of Left Atrial Appendage for Patients With Atrial Fibrillation and Ischemic StrokE Despite Anticoagulation Therapy
Status: Not yet recruiting, Estimated PCD: 2028-01-01
Product
DOAC
Clinical trial
Effect of Early Versus Late Initiation of Edaravone Dexborneol on Neural Function in Patients With Acute Ischemic Stroke-A Multicenter, Randomized, Double-blind, Placebo-controlled, Trial
Status: Not yet recruiting, Estimated PCD: 2024-12-31
Product
Edaravone Dexborneol
Clinical trial
Early Intensive Medical Therapy for the Prevention of Early Neurological Deterioration in Branch Atheromatous Disease
Status: Recruiting, Estimated PCD: 2024-02-28
Clinical trial
PLAsticity, Security and Tolerance to Intermittent Hypoxic Conditioning Following Stroke
Status: Withdrawn, Estimated PCD: 2024-01-01
Product
Hypoxia
Clinical trial
Helping Stroke Patients With ThermoSuit Cooling
Status: Terminated, Estimated PCD: 2023-06-01
Product
Magnesium Sulfate
Product
tPA
Product
Etomidate
Clinical trial
EVOLVE-MI: A Pragmatic Randomized Multicenter Trial of EVOLocumab Administered Very Early to Reduce the Risk of Cardiovascular Events in Patients Hospitalized With Acute Myocardial Infarction
Status: Active (not recruiting), Estimated PCD: 2027-05-31
Product
Evolocumab
Clinical trial
Regenerative Stem Cell Therapy for Stroke in Europe 1
Status: Recruiting, Estimated PCD: 2025-07-01
Product
Adipose derived Stem Cell
Product
Routine Lipid Management
Clinical trial
A Single Center, Pilot Study of Induced Hypertension for Minimizing Infarct Progression in Patients With Acute Large-vessel Occlusion Ischemic Stroke Undergoing Endovascular Therapy
Status: , Estimated PCD: 2024-06-01
Product
Phenylephrine
Clinical trial
Aspirin Combined With Clopidogrel Versus Intravenous Alteplase for Acute Minor Stroke: An Open-label, Blinded Endpoint, Randomized Controlled Trial
Status: Not yet recruiting, Estimated PCD: 2027-07-01
Clinical trial
Allogeneic Adipose Tissue-derived Mesenchymal Stem Cells in Ischemic Stroke. A Phase IIB Multicenter Double Blind Placebo Controlled Clinical Trial
Status: , Estimated PCD: 2023-07-15
Clinical trial
Adopting a Precision Medicine Paradigm in Puerto Rico: Leveraging Ancestral Diversity to Identify Predictors of Clopidogrel Response in Caribbean Hispanics
Status: Active (not recruiting), Estimated PCD: 2023-04-30
Product
CYP2C19
Clinical trial
Modafinil and Exercise for Post Stroke Fatigue (MODEX)
Status: Not yet recruiting, Estimated PCD: 2027-09-01
Clinical trial
Activation of Peripheral TRPM8 Mitigates Acute Ischemic Stroke by Topically Applied Menthol
Status: Not yet recruiting, Estimated PCD: 2024-05-31
Product
Menthol
Clinical trial
General Anesthesia Versus Sedation During Intra-arterial Treatment for Stroke
Status: Completed, Estimated PCD: 2020-08-01
Product
Succinylcholine
Product
Remifentanil
Clinical trial
Improving Neuroprotective Strategy for Ischemic Stroke With Poor Recanalization After Thrombectomy by Intra-arterial TNK (INSIST-TNK): a Prospective, Single Arm, Pilot Study
Status: Recruiting, Estimated PCD: 2023-12-30
Clinical trial
Prevention of Stroke by Left Atrial Appendage Closure in Atrial Fibrillation Patients After Intracerebral Hemorrhage: A Multicenter Randomized Clinical Trial
Status: , Estimated PCD: 2027-12-01
Product
Medical Therapy
Clinical trial
The Optimal Anticoagulation for Enhanced Risk Patients Post-Catheter Ablation for Atrial Fibrillation Trial
Status: Active (not recruiting), Estimated PCD: 2025-07-01
Clinical trial
A 2 x 2 Factorial Randomized Clinical Trial Evaluating Anti-inflammatory and Anti-thrombotic Strategy in Acute Ischemic Stroke
Status: Not yet recruiting, Estimated PCD: 2026-06-01
Clinical trial
Suhexiang Pill for Acute Ischemic Stroke: A Prospective Registry Study of Real-world Data
Status: Recruiting, Estimated PCD: 2024-12-31
Product
Suhexiang
Clinical trial
A Novel Wrist Wearable Sensor System to Promote Hemiparetic Upper Extremity Use in Home Daily Life of Chronic Stroke Survivors
Status: Not yet recruiting, Estimated PCD: 2025-06-30
Product
StrokeWear Motor and Behavioral Intervention
Clinical trial
Acupuncture Therapy Combined With Breathing Training for Patients With Stroke Complicated With Pulmonary Infection: A Clinical Study
Status: Completed, Estimated PCD: 2021-05-31
Product
Conventional drug therapy
Clinical trial
A Multi-Center, Prospective, Open Label, Phase IIa Trial of RP-1127 (Glyburide for Injection) in Patients With a Severe Anterior Circulation Ischemic Stroke Who Are Likely to Experience Clinically Significant Brain Swelling.
Status: Completed, Estimated PCD: 2012-06-07
Clinical trial
A Phase 3, Multicenter, Prospective, Randomized, Open-label, Blinded-endpoint (PROBE) Controlled Trial of Tenecteplase Versus Standard Medical Treatment for Acute Ischemic Stroke Due to Anterior Circulation Large Vessel Occlusion With Perfusion Mismatch up to 24 Hours of Symptom Onset
Status: Completed, Estimated PCD: 2024-01-29
Clinical trial
A Multicenter Prospective Randomized-controlled Interventional Study to Evaluate the Effect of High Dose Rosuvastatin Versus High Dose Rosuvastatin and Ezetimibe in Acute Ischemic Stroke Patients
Status: Recruiting, Estimated PCD: 2023-12-31
Product
Rosuvastatin + Ezetimibe
Product
High-dose Rosuvastatin
Clinical trial
Intra-arterial Alteplase for Acute Ischemic Stroke After Mechanical Thrombectomy (PEARL): A Multicenter, Prospective, Open-label, Blinded Endpoint, Randomized Controlled Trial
Status: Recruiting, Estimated PCD: 2025-12-01
Clinical trial
Umbilical Cord-derived Mesenchymal Stem Cells for Ischemic Stroke (UMSIS): a Prospective, Double-blinded, Randomized Controlled, Pilot Study
Status: Recruiting, Estimated PCD: 2024-06-01
Product
Umbilical Cord-derived Mesenchymal Stem Cells
Product
Modafinil
Clinical trial
Prospective, Multicenter, Open, End-point Blinded, Stratified Block Randomized, Parallel Positive Controlled Clinical Trial of Tenecteplase in Acute Ischemic Stroke With Large Vessel Occlusion Over Time Window
Status: Completed, Estimated PCD: 2023-09-30
Clinical trial
Neurocognitive Impairment Assessment in Symptomatic Carotid Occlusion Recanalized Endovascularly
Status: Completed, Estimated PCD: 2024-03-14
Product
Aspirin + Clopidogrel
Clinical trial
The Effect of Prismatic Lenses in Association With tDCS in Patients With Neglect: a Pilot Study
Status: Recruiting, Estimated PCD: 2024-07-30
Product
Prismatic adaptation and electric stimulation
Clinical trial
AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke
Status: Terminated, Estimated PCD: 2023-03-31
Clinical trial
CHemical OptImization of Cerebral Embolectomy in Patients With Acute Stroke Treated With Mechanical Thrombectomy 2 (CHOICE 2 TRIAL)
Status: Not yet recruiting, Estimated PCD: 2025-03-01
Clinical trial
A Randomized, Blinded, Placebo-Controlled Phase 2B Clinical Trial to Compare the Efficacy of Different Combinations of Sodium Chloride and Sodium Acetate IV Fluids Along With Standard of Care Treatment in Acute Stroke Patients.
Status: Recruiting, Estimated PCD: 2024-02-28
Product
Sodium Chloride 0.9% infusion
Clinical trial
Clinical Significance of Circulating Non-coding RNA in Acute Ischemic Stroke (AISRNA)
Status: Recruiting, Estimated PCD: 2024-12-31
Product
Sequencing of circRNA/miRNA/lncRNA
Clinical trial
A Phase Ib Dose-Escalation Study of Intra-arterial Albumin Infusion After Endovascular Therapy for Stroke Patients
Status: Not yet recruiting, Estimated PCD: 2024-02-29
Product
Albumin
Clinical trial
Emergent Intravenous Dye Preparation for Acute Stroke Patients With a History of Intravenous Dye Allergy
Status: , Estimated PCD: 2019-01-18
Product
Emergent IV Dye
Product
Standard Medical Treatment
Clinical trial
Endovascular Treatment With or Without Preceding Intravenous Tenecteplase (TNK) in Patients With Late-window acUte Ischemic Stroke Due to Middle Cerebral Artery Occlusion: a Multi-center, Prospective, Open-label, Blinded Endpoint (PROBE), Phase 3, Randomized Controlled Trial
Status: Recruiting, Estimated PCD: 2024-12-01
Product
rhTNK-tPA
Clinical trial
Clinical Significance of Circulating Non-coding RNA in Acute Ischemic Stroke With Endovascular Treatment (EVTRNA)
Status: Recruiting, Estimated PCD: 2024-03-01
Product
Sequencing of circRNA/lncRNA/miRNA
Clinical trial
A Randomized,Double Blind,Placebo Parallel Controlled,Multicenter Clinical Sthdy of Ginkgo Diterpene Lactone Meglumine Injection for Acute Ischemic Stroke Efficacy Safety.
Status: Completed, Estimated PCD: 2018-05-01
Product
Ginkgo diterpene lactone
Clinical trial
Intravenous rhTNK-tPA Bridging With Endovascular Treatment Versus Endovascular Treatment Alone For Stroke Patient With Large Vessel Occlusion: A Multicenter, Randomized Controlled Trial
Status: Recruiting, Estimated PCD: 2025-12-31
Clinical trial
Safety and Efficacy of Glibenclamide Combined With Rt-PA in Treating Acute Ischemic Stroke: a Prospective, Randomized, Double-blind, Placebo-control, Multi-center Study
Status: Completed, Estimated PCD: 2022-08-28
Product
Glibenclamide
Clinical trial
Comparison of Combined Pioglitazone and SGLT2 Inhibitors vs. DPP4 Inhibitors in Diabetic Patients With Ischemic Stroke: Rationale and Study Design
Status: Recruiting, Estimated PCD: 2023-07-31
Product
Metformin + Pioglitazone + SGLT2 inhibitor
Clinical trial
Intra-arterial Tenecteplase During First Thrombectomy Attempt for Acute Stroke (BRETIS-TNK II): a Prospective, Randomized, Adaptive Enrichment, Open-label, Blinded End Point, Multi-center Study
Status: Recruiting, Estimated PCD: 2025-03-15
Clinical trial
Early Antiplatelet for Minor Stroke Following Thrombolysis (EAST): a Prospective, Random, Double Blinded and Multi-center Study
Status: Recruiting, Estimated PCD: 2024-07-28
Clinical trial
Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Trial of the Efficacy and Safety of SPT-07A Injection in Patients With Acute Ischemic Stroke
Status: Recruiting, Estimated PCD: 2024-01-10
Product
SPT-07A
Clinical trial
Improving Neurological Outcome for Acute Basilar Artery Occlusion With Sufficient Recanalization After Thrombectomy by Intraarterial Tenecteplase (INSIST-IT): a Prospective, Randomized, Open-label, Blinded-end Point, Multicenter Trial
Status: Recruiting, Estimated PCD: 2025-03-15
Clinical trial
A Phase I Study of Safety and Tolerability of Single-dose Human Umbilical Cord Mesenchymal Stem Cell (IxCell hUC-MSC-S) in Patients With Convalescent Phase of Ischemic Stroke
Status: Not yet recruiting, Estimated PCD: 2024-06-01
Product
MSC
Clinical trial
Outcomes of Umbilical Cord Blood-derived Mesenchymal Stem Cell Infusion in Patients With Neurological Complications After Ischemic Stroke
Status: Completed, Estimated PCD: 2022-12-30
Product
UC-MSC infusion
Product
UC-MSC
Clinical trial
Outcome in Patients Treated With Intraarterial Thrombectomy - optiMAL Blood Pressure Control (OPTIMAL-BP)
Status: Active (not recruiting), Estimated PCD: 2024-12-01
Product
Conventional Blood Pressure Control (Labetalol, Nicardipine)
Product
Intensive Blood Pressure Control (Labetalol, Nicardipine)
Clinical trial
A Randomized, Open and Routine Parallel Controlled Clinical Study on the Safety and Efficacy of Autologous Bone Marrow Mesenchymal Stem Cells (BMSCs) Transplantation in the Treatment of Ischemic Stroke
Status: Recruiting, Estimated PCD: 2024-11-30
Product
Transplantation of self BMSCs
Clinical trial
CONVINCE - (COlchicine for preventioN of Vascular Inflammation in Non- CardioEmbolic Stroke) - a Randomised Clinical Trial of Low-dose Colchicine for Secondary Prevention After Stroke
Status: Active (not recruiting), Estimated PCD: 2022-11-21
Clinical trial
Endovascular Thrombectomy With and Without Intravenous Thrombolysis for Large Vessel Anterior Circulation Stroke in Extended Time Window
Status: Recruiting, Estimated PCD: 2024-11-28
Product
Intravenous thrombolysis agents
Clinical trial
Reducing Intracranial atheroSclErosis With Repatha
Status: Terminated, Estimated PCD: 2021-12-16
Product
Repatha
Clinical trial
Systemic Inflammation During Recanalization of Cerebral Arterial Occlusion
Status: Completed, Estimated PCD: 2021-06-12
Clinical trial
Hyperbaric Oxygen Treatment in Chronic Stroke a Feasibility Study
Status: Completed, Estimated PCD: 2022-12-30
Product
Hyperbaric oxygen
Clinical trial
Solitaire™ With the Intention For Thrombectomy Plus Intravenous t-PA Versus DIRECT Solitaire™ Stent-retriever Thrombectomy in Acute Anterior Circulation Stroke
Status: Completed, Estimated PCD: 2021-05-14
Product
Recombinant tissue-type plasminogen activator
Clinical trial
The Effect of Glucagon-like Peptide 1 (GLP-1) Receptor Agonist on Cerebral Blood Flow Velocity in Stroke Patients
Status: Recruiting, Estimated PCD: 2023-08-01
Product
Normosaline
Clinical trial
Stent Implantation Versus Balloon Dilation for Acute Anterior Circulation Tandem Occlusion: A Multicenter, Prospective, Randomized, Open-label, Blinded End-point Trial
Status: Recruiting, Estimated PCD: 2025-06-01
Product
Dual antiplatelet treatment
Product
Intraoperative Drug Treatment
Clinical trial
Antithrombotic Drug Use in Patients With Ischemic Stroke and Microbleeds
Status: Recruiting, Estimated PCD: 2025-12-01
Clinical trial
Treatment of Acute Post-stroke Oropharyngeal Dysphagia With Paired Stimulation Through Peripheral TRVP1 Agonists and Non-invasive Brain Stimulation
Status: Recruiting, Estimated PCD: 2023-12-01
Product
Piperine
Product
Piperine + tDCS
Product
Capsaicin
Clinical trial
Use of Oral Anticoagulants and Symptoms in Patients With Atrial Fibrillation in Örebro County
Status: Completed, Estimated PCD: 2021-01-29
Clinical trial
Tenecteplase REperfusion in Acute Ischemic sTroke Registry
Status: Recruiting, Estimated PCD: 2024-09-30
Clinical trial
Diffuse Optical Monitoring With Inhaled Nitric Oxide
Status: Active (not recruiting), Estimated PCD: 2025-07-01
Product
Nitric Oxide
Clinical trial
A Multi-faCtorial, mulTi-arm, Multi-staGe, Randomised, gLOBal Adaptive pLatform Trial for Stroke (ACT-GLOBAL)
Status: Not yet recruiting, Estimated PCD: 2034-05-01
Product
Low-dose intravenous tenecteplase
Product
NoNO-42
Clinical trial
A Multi-centre, Prospective, Randomized, Open-label, Blinded Endpoint (PROBE) Controlled Trial Comparing Cervical Internal Carotid Artery Stenting to no Stenting During Thrombectomy for Tandem Occlusion Stroke
Status: Recruiting, Estimated PCD: 2026-06-01
Product
Antiplatelet Agents
Clinical trial
EXtending the Time Window for Thrombolysis in Posterior Circulation Stroke Without Early CT Signs
Status: Recruiting, Estimated PCD: 2024-05-30
Product
Tissue Plasminogen Activator
Clinical trial
Clevidipine Infusion for Blood Pressure Management After Successful Revascularization in Acute Ischemic Stroke (CLEVER)
Status: Recruiting, Estimated PCD: 2025-01-01
Product
Clevidipine
Clinical trial
Liraglutide in Acute Minor Ischemic Stroke or High-risk Transient Ischemic Attack Patients With Type 2 Diabetes Mellitus: A Prospective, Multicenter, Randomized, Blank-controlled，Blinded End-point Study.
Status: Recruiting, Estimated PCD: 2023-12-01
Product
Liraglutide
Clinical trial
Priming Effects of Aerobic Exercise on Cognitive Training of Patients With Ischemic and Hemorrhagic Stroke
Status: Recruiting, Estimated PCD: 2023-05-01
Product
BDNF
Clinical trial
A Randomised Controlled Trial of Combinating an Immune Modulator Fingolimod With Alteplase Bridging With Mechanical Thrombectomy in Acute Ischemic Stroke
Status: Recruiting, Estimated PCD: 2025-12-15
Product
Fingolimod
Product
Antithrombotic drugs
Clinical trial
A Real-world Study on the Effectiveness and Safety of Butylphthalide in the Treatment of Ischemic Stroke.
Status: Recruiting, Estimated PCD: 2025-09-01
Product
Butylphthalide
Clinical trial
Dopaminergic Enhancement of Rehabilitation Therapy Early After Stroke
Status: Completed, Estimated PCD: 2024-03-11
Product
Sinemet
Clinical trial
Intensive Statin and Antiplatelet Therapy for High-risk Intracranial or Extracranial Atherosclerosis (INSPIRES)
Status: Active (not recruiting), Estimated PCD: 2023-01-15
Product
Intensive Antiplatelet
Product
Standard antiplatelet
Product
Immediate high-intensity statin
Product
Delayed high-intensity statin
Clinical trial
Efficacy and Safety of Sodium Oligomannate in the Prevention of Post-stroke Cognitive Impairment in Patients With Ischemic Stroke:a Randomized, Double-blind, Exploratory Controlled Study
Status: Not yet recruiting, Estimated PCD: 2023-12-31
Product
Sodium Oligomannate
Clinical trial
Efficacy and Safety of Sarecycline in Patients With Acute Ischemic Stroke After Reperfusion Therapy: A Phase II, Randomized, Multicenter, Double-blind, Single Dose, Placebo-controlled Parallel Trial
Status: Recruiting, Estimated PCD: 2023-11-01
Product
Sarecycline
Clinical trial
Registration of Intravenous Thrombolysis for Acute Ischemic Stroke in Southwestern China（IVTIS）
Status: Recruiting, Estimated PCD: 2045-12-15
Product
Intravenous Thrombolysis
Clinical trial
Effect of Human Umbilical Cord Mesenchymal Stem Cells(MSCs) Transplantation for on Prognosis of Acute Cerebral Infarction Patients
Status: Recruiting, Estimated PCD: 2024-12-30
Product
Human Umbilical Cord Mesenchymal Stem Cells
Clinical trial
Identification of Biomarkers in Ischemic Stroke - Clinical Trial
Status: Completed, Estimated PCD: 2024-02-06
Product
Blood Samples
Clinical trial
A Randomized Controlled Trial Assessing the Efficacy and Safety of Normobaric Hyperoxia for Acute Ischemic Stroke Patients Undergoing Endovascular Treatment
Status: Completed, Estimated PCD: 2023-05-05
Product
Normobaric Hyperoxia
Product
Sham Normobaric Hyperoxia
Clinical trial
Stroke Prevention in Young Adults With Sickle Cell Anemia
Status: Active (not recruiting), Estimated PCD: 2029-06-01
Product
Hydroxyurea
Clinical trial
Rescue Thrombolysis for Medium Vessel Occlusion (RESCUE-TNK): a Prospective, Randomized, Open-label, Blinded End Point, and Multicenter Trial
Status: Recruiting, Estimated PCD: 2025-03-15
Clinical trial
Effect of Intensive Nutritional Support on Functional Recovery in Subacute Stroke Patient
Status: Completed, Estimated PCD: 2023-08-31
Product
Omapone Peri
Clinical trial
Alteplase Compared to Tenecteplase in Patients With Acute Ischemic Stroke: QuICR & OPTIMISE Registry Based Pragmatic Randomized Controlled Trial
Status: Completed, Estimated PCD: 2022-04-26
Clinical trial
Efficacy of the CHM Teabag in Decreasing Stroke Risk Among Elderly People in Hong Kong: A Stepped Wedge Cluster Randomized Trial
Status: Recruiting, Estimated PCD: 2023-08-30
Product
Chinese Herbal Medicine (CHM)
Clinical trial
Concomitant Use of Clopidogrel With Atorvastatin or Rosuvastatin in Patients With Minor Stroke or TIA, a Randomized Controlled Single-blinded Trial
Status: Recruiting, Estimated PCD: 2025-04-10
Clinical trial
Primary Prevention of Stroke in Children With Sickle Cell Anaemia in Nigeria: Community vs Teaching Hospital
Status: Recruiting, Estimated PCD: 2025-07-31
Drug
hydroxyurea
Clinical trial
Safety and Efficacy of Intra-arterial Tenecteplase for Noncomplete Reperfusion of Intracranial Occlusions
Status: Recruiting, Estimated PCD: 2025-07-31
Clinical trial
Intra-arterial Autologous Bone-marrow Mononuclear Cells Infusion for Acute Ischemic Stroke. A Phase II, Open-label, Multicenter, Randomized and Controlled Clinical Trial.
Status: Completed, Estimated PCD: 2021-10-27
Product
Autologous bone marrow mononuclear cell
Clinical trial
The Safety and Efficacy of Normobaric Hyperoxia Combined With Reperfusion for Acute Ischemic Stroke：A Randomized, Controlled Pilot Study
Status: Completed, Estimated PCD: 2019-07-21
Product
Normobaric oxygen
Clinical trial
Effect of Antiseizure Medication in Seizure Networks at Early Stages of Acute Brain Injury. The Rs-fMRI, Open-label Pilot Trial
Status: Recruiting, Estimated PCD: 2024-11-01
Product
Phenobarbital Sodium
Product
Levetiracetam
Product
Lacosamide
Product
Valproate
Clinical trial
Effect of Atrial Fibrillation Burden on Long-term Risk of Thromboembolic Complications- the FinCV-4 Study
Status: Active (not recruiting), Estimated PCD: 2025-01-08
Product
Anticoagulation Therapy
Product
Phosphenytoin
Clinical trial
Intra-arterial Neuroprotective Strategy for Ischemic STroke Patients With Endovascular Therapy (INSIST-ET): One Single Center, Safety and Feasibility Study
Status: Recruiting, Estimated PCD: 2025-12-31
Product
Neuroprotective agents
Clinical trial
Efficacy and Safety of Tirofiban Versus Placebo After Successful Reperfusion With Endovascular Thrombectomy in Acute Ischemic Stroke Patients With Anterior Circulation Large Vessel Occlusion: a Multicenter, Double-Blind, Randomized Clinical Trial
Status: Not yet recruiting, Estimated PCD: 2026-07-31
Product
Intraarterial and Intravenous Placebo
Clinical trial
Biological Bank for Studies Related to Atrial Fibrillation and Stroke
Status: Recruiting, Estimated PCD: 2029-04-23
Clinical trial
INtravenous TNK for Acute isChemicsTroke in China (INTACT-China): a Prospective, Multi-center, Registry Study
Status: Completed, Estimated PCD: 2024-04-09
Clinical trial
Colchicine in High-risk Patients With Acute Minor-to-moderate Ischemic Stroke or Transient Ischemic Attack (CHANCE-3)
Status: Recruiting, Estimated PCD: 2024-04-30
Clinical trial
Impact of the Genetic Background as a Risk Factor for Atherosclerotic Cardiovascular Disease in the Brazilian Population
Status: Active (not recruiting), Estimated PCD: 2023-02-20
Product
Exposure to genetics
Clinical trial
A Randomized, Open-label, Investigator-initiated, Pilot Clinical Trial Comparing the Improvement for Ankle Brachial Index and Safety of Sarpogrelate and Clopidogrel in Stroke Patients Accompanying Lower Extremity Vascular Atherosclerosis With Decrease of Ankle Brachial Index and Intermittent Claudication.
Status: Not yet recruiting, Estimated PCD: 2028-06-30
Product
Sarpogrelate
Clinical trial
Gait Training Combined With Strategies to Induce Transference to Real Life for People With Stroke
Status: Completed, Estimated PCD: 2023-02-10
Product
Treadmill training + transfer package (TT+TP)
Clinical trial
Alteplase-Tenecteplase Trial Evaluation for Stroke Thrombolysis (ATTEST 2)
Status: Completed, Estimated PCD: 2023-08-31
Clinical trial
Association of Osteopontin Gene Polymorphisms With Susceptibility and Prognosis of Ischemic Stroke in Egyptian Patients
Status: Not yet recruiting, Estimated PCD: 2024-09-01
Product
Gene polymorphism
Clinical trial
A Prospective Observational Cohort Study of Predictive Factors Related to Prognosis of In-hosiptal Patients With Ischemic Stroke Due to Large-artery Atherosclerosis
Status: Recruiting, Estimated PCD: 2026-12-31
Clinical trial
Molecular Characteristics of Phlegm-heat Syndrome in Ischemic Stroke: A Cohort Study
Status: Not yet recruiting, Estimated PCD: 2024-12-31
Product
Guideline-based treatment
Clinical trial
Extending the Time Window for Tenecteplase by Effective Reperfusion of peNumbrAL Tissue in Patients With Large Vessel Occlusion
Status: Recruiting, Estimated PCD: 2025-06-01
Product
Standard Care
Clinical trial
Improving Early Reperfusion With Adjuvant Dornase Alfa in Large Vessel Ischemic Stroke (EXTEND-IA DNase)
Status: Recruiting, Estimated PCD: 2025-09-30
Clinical trial
Stroke Prevention In Ischemic Stroke With Covert Atrial Fibrillation
Status: Not yet recruiting, Estimated PCD: 2025-09-01